Abstract
Background:
Post-COVID syndrome, defined by the WHO as persistent multisystem symptoms extending beyond 4 weeks post-infection, has emerged as a critical public health concern in South Asia, a region home to approximately 1. 9 billion individuals across Pakistan, India and Bangladesh. Despite the disproportionate burden affecting an estimated 54.3 million individuals in this region, no prior systematic synthesis has integrated evidence across all three major South Asian countries, creating a significant gap in the evidence-based policy development.
Methods:
This systematic narrative review, conducted following the PRISMA-ScR guidelines, synthesized evidence from 388 peer-reviewed publications identified through PubMed, Scopus, and Google Scholar databases (January 2020–December 2023). Study quality was assessed using the JBI Critical Appraisal Checklist and the GRADE framework. Two independent reviewers performed the screening (inter-rater reliability: 87.3%) and data extraction (concordance: 94.1%).
Results:
The prevalence of post-COVID syndrome varied geographically: 15.8%−18.3% in Pakistan, 9.4%−22.5% to 11.2%−16.8% in India, Females consistently demonstrated higher prevalence across all countries, with ratios ranging from 1.41:1 to 1.81:1. The peak burden occurred in the 35–54 age group. Urban areas reported a higher prevalence than rural areas, with disparities correlating with healthcare infrastructure metrics. Fatigue (58.3%), brain fog (52.1%), and memory problems (48.7%) were the most prevalent symptoms. The prevalence declined across successive pandemic waves, with vaccination associated with substantial reductions in later waves.
Conclusion:
Post-COVID syndrome poses a substantial and ongoing public health challenge in South Asia, disproportionately affecting women and adults of working age. Urban-rural disparities in prevalence reflect underlying healthcare access inequities rather than true epidemiological differences. Urgent priorities include establishing dedicated post-COVID clinics, strengthening rehabilitation infrastructure, and conducting region-specific genetic and long-term outcome research to inform evidence-based interventions for this vulnerable population.
1 Introduction
COVID-19′s long-term sequelae are characterized by four overlapping terms with distinct clinical implications. “Long COVID” serves as an umbrella term for any prolonged consequence following SARS-CoV-2 infection, lacking formal diagnostic criteria and yielding wide prevalence estimates unsuitable for clinical diagnosis (, ). In contrast, “post-COVID syndrome” aligns with the WHO-standardized definition, requiring six key criteria: documented SARS-CoV-2 infection, new-onset or persistent symptoms, symptom onset at least 4 weeks after infection, symptoms lasting at least 4 weeks, functional impairment, and multisystem involvement. Studies adhering to these WHO criteria consistently report prevalence rates of 14%−17%, facilitating reliable international comparisons (, ). “Post-COVID condition” employs identical diagnostic criteria but represents a linguistic shift to avoid implying a specific etiology, while “post-COVID sequelae” broadly describes consequences without specificity on temporal duration, severity, or diagnostic thresholds (, –). To ensure methodological rigor and international comparability, this review adopted the WHO post-COVID syndrome criteria ().
These terminological distinctions are crucial for accurate epidemiological reporting, particularly in resource-limited regions such as South Asia with pronounced urban-rural healthcare disparities (, , ). Definitional choices profoundly influence prevalence estimates: WHO 6-criteria studies yield consistent 14%−17% rates globally (, ), while broad any-symptom definitions report 22%−34% or higher (, ), accounting for approximately 60% of observed variations unrelated to true epidemiology. This definitional heterogeneity directly explains the wide South Asian post-COVID syndrome prevalence range of 9.4%−34.2% (, ).
South Asia, home to approximately 1.9 billion individuals across Pakistan, India, and Bangladesh, faces post-COVID syndrome as one of the most pressing public health challenges worldwide. Standardized prevalence rates range from 9.4% to 22.5%, placing South Asia at or above the upper end of global WHO criteria estimates (, , –). This translates to a projected total of 54.3 million affected individuals, representing 12.8% of the estimated 427 million global post-COVID cases, imposing disproportionate strain on already resource-constrained healthcare systems (, –). The pathophysiology involves persistent viral reservoirs, dysregulated immune responses, and microthrombotic processes, which collectively drive prolonged symptoms (, ).
1.1 Research gap and rationale
Despite South Asia containing 54.3 million affected individuals, representing 12.8% of the global burden, no prior systematic synthesis has integrated evidence across all three major South Asian countries (Pakistan, India, and Bangladesh). Existing reviews have either focused on individual countries or global estimates without stratifying South Asian data by sex, age, urban-rural setting, and pandemic wave. This critical knowledge gap prevents the development of evidence-based, region-specific policies for post-COVID syndrome management in a population already strained by limited healthcare resources (, –).
1.2 Aims and objectives
This systematic narrative review aims to (1) synthesize and compare post-COVID syndrome prevalence data across Pakistan, India, and Bangladesh; (2) identify gender-specific, age-stratified, and urban-rural patterns in post-COVID syndrome burden; (3) document and categorize clinical manifestations by organ system across the region; (4) assess healthcare system responses, capacity gaps, and rehabilitation outcomes; and (5) provide actionable, evidence-based recommendations for clinicians, policymakers, and researchers to mitigate the post-COVID syndrome burden in South Asia.
2 Research strategy and methodology
2.1 Study design and methodological approach
This comprehensive review employed a systematic narrative review methodology following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines (Supplementary File 1: PRISMA-ScR Checklist), which is ideal for mapping heterogeneous evidence landscapes where traditional meta-analyses are infeasible due to inconsistent definitions, diverse study designs, and high statistical heterogeneity across global and regional post-COVID syndrome studies (, , ). This approach enabled synthesis of diverse study designs, heterogeneous South Asian populations, and varied outcome measurements while permitting nuanced discussions of methodological variations, regional contextual factors, healthcare system differences, and cultural influences (, , –). Full Boolean search strategies for each database (PubMed, Scopus, and Google Scholar) are provided in Additional File 2: database search strategies.
2.2 Information sources and database searches
On November 19, 2025, searches of PubMed yielded 3,847 articles, Scopus identified 2,134 articles, and Google Scholar located 1,256 publications (, ). The combined initial yield was 7,237 records. Following systematic deduplication using EndNote X20, 5,812 unique articles were retained. A quality-control audit of 50 removed duplicates confirmed an accuracy of 98% (). Screening was conducted by two independent reviewers, with a third reviewer resolving disagreements (, ). PubMed, Scopus, and Google Scholar were selected because together they provide broad, complementary coverage of biomedical and public-health literature relevant to South Asia, with PubMed offering optimal indexing for clinical topics, Scopus adding extensive international and regional journal coverage, and Google Scholar improving capture of gray and regionally indexed literature. CINAHL, Embase, and Web of Science were not searched because our focus was epidemiological and clinical rather than nursing-specific, and because these subscription databases are not consistently accessible across collaborating South Asian institutions; current evidence-based guidance recommends tailoring database selection to both content coverage and feasibility in resource-constrained settings.
2.3 Screening process with inter-rater reliability
A total of 5,812 unique records underwent title and abstract screening. The inter-rater reliability was substantial, with a raw concordance rate of 87.3%. Consequently, 1,043 articles underwent full-text evaluation. Author contact for clarification was pursued in 12 articles, yielding responses from 10. Ultimately, 388 articles satisfied the inclusion criteria, equating to 38.8% of the full-text reviews and 6.7% of the deduplicated initial yield.
2.4 Inclusion and exclusion criteria
Inclusion criteria: original peer-reviewed research; cohort studies, cross-sectional surveys, case series, systematic reviews, or meta-analyses; confirmed post-COVID syndrome lasting ≥4 weeks; South Asian population focus; measurement of post-COVID syndrome manifestations, prevalence, risk factors, or management approaches.
Exclusion criteria: opinion pieces, editorials, and commentaries lacking original data; case series with < 10 cases; non-English publications; preprints without peer review; non-South Asian populations; acute COVID-19 treatment studies; and duplicate datasets.
2.5 Data extraction and quality assessment
Custom extraction forms standardized per the PRISMA-ScR and JBI guidelines documented study characteristics, population demographics, and post-COVID syndrome outcomes (–). Data extraction was performed independently by two reviewers using Excel templates, with discrepancies resolved by consensus, yielding a 94.1% concordance (, ). The GRADE framework was used to assess the certainty (–). The methodological quality was evaluated using the JBI Critical Appraisal Checklist for Studies Reporting Prevalence Data (). Statistical analyses were performed using Comprehensive Meta-Analysis V3 software with random-effects models and 95% confidence intervals (). Heterogeneity was quantified using the I2 statistic and Cochran's Q–test (, ). Publication bias was assessed using funnel plots and Egger's regression test (–).
3 Results
3.1 Post-COVID syndrome prevalence in South Asia: regional burden
The prevalence of South Asian post-COVID syndrome ranges from 11.2 to 34.2% depending on geographic location, viral variant, healthcare infrastructure, and demographic factors (, , , ) (Table 1, Figure 3).
Table 1
| Country | Overall Prevalence | Female (%) | Male (%) | F:M Ratio | Peak Age | Urban (%) | Rural (%) | Urban-rural gap (pp) |
|---|---|---|---|---|---|---|---|---|
| Pakistan | 15.8–18.3 | 22.4–25.6 | 16.1–18.9 | 1.41:1 | 35–44 | 17.2 | 14.1 | 3.1 |
| India | 9.4–22.5 | 18.3–28.4 | 10.1–16.2 | 1.81:1 | 35–54 | 20.1 | 8.3 | 11.8 |
| Bangladesh | 11.2–16.8 | 16.4–21.2 | 11.0–14.5 | 1.61:1 | 35–44 | 15.3 | 9.2 | 6.1 |
| Regional avg | 21.3 | 24.1 | 16.2 | 1.61:1 | 35–54 | 17.5 | 10.5 | 7.0 |
Country-specific post-COVID syndrome prevalence and demographics.
3.1.1 Country-specific epidemiology
Pakistan exhibits a post-COVID syndrome prevalence of 15.8%−18.3%, pooled from 18 studies involving 68,432 participants (, , ). Females demonstrate higher rates of 22.4%−25.6% compared to males at 16.1%−18.9%, yielding a female-to-male ratio of 1.41:1 (, , , ). The peak prevalence occurs in the 35–44 age group (). Urban-rural disparity is modest at 3.1 percentage points, reflecting Pakistan's intermediate healthcare infrastructure (, , , ). The estimated affected population is approximately 2.5 million individuals ().
India exhibits the widest post-COVID syndrome prevalence range of 9.4%−22.5%, driven by pronounced regional variation and substantial urban-rural healthcare access disparities (, ). Urban centers report prevalence rates of 20.1%, whereas rural areas record 8.3%, resulting in the most substantial gap of 11.8 percentage points (, ). Females experience higher prevalence rates of 18.3%−28.4% compared to males at 10.1%−16.2%, yielding the highest female-to-male ratio of 1.81:1 across South Asia (). The estimated affected population is approximately 6.3 million (, ).
Bangladesh exhibits an intermediate post-COVID syndrome prevalence rate of 11.2%−16.8%, pooled from 14 studies involving 52,341 participants. Females experience higher rates of 16.4%−21.2% compared to 11.0%−14.5% among males, yielding a female-to-male ratio of 1.61:1 (). A moderate urban-rural disparity of 6.1 percentage points exists (, , , ). The estimated affected population is approximately 0.35 million () (Figure 1).
Figure 1
3.1.2 Critical analysis
The 3.6-fold prevalence range reflects approximately 60% definition inconsistency and 40% genuine epidemiological differences related to healthcare infrastructure, genetic factors, occupational exposures, and viral variants (, , ). These patterns align with broader global trends, where South America reports the highest pooled post-COVID syndrome prevalence at 51%, underscoring South Asia's substantial burden relative to other regions despite resource constraints (, , ) (Figure 2).
Figure 2
3.2 Clinical manifestations by organ system
3.2.1 Respiratory manifestations
Dyspnea affects 42.3% of patients with post-COVID syndrome (). Hospital-based studies reported 48.2% dyspnea prevalence vs. 35.1% in community-based surveys, indicating a 13.1 percentage point selection bias (, , ). Persistent cough was reported by 38.1% of patients, with a female-to-male ratio of 1.40:1 and a mean duration of 8.3 ± 4.2 weeks. Exercise intolerance affected 35.7% of patients, with 68% reporting significant functional limitations that impeded occupational activities. Reduced lung function was observed in 28.4% of patients, with a mean FEV1 decline of 12.3 ± 8.2% ().
3.2.2 Cardiovascular manifestations
Palpitations affect 31.2%, chest pain 28.6% (), dysrhythmias 12.4% (), new-onset hypertension 15.2%, and orthostatic intolerance 18.7% (, ).
3.2.3 Neuropsychiatric manifestations
Brain fog affects 52.1% of individuals with significant functional disabilities (62). Female predominance across all neuropsychiatric manifestations reflects three contributing mechanisms: biological sex differences including estrogen-dependent immune responses and ACE2 expression patterns; occupational-economic factors where 82% of affected women are in informal sector roles; and reporting biases where females report psychiatric symptoms 1.6 times more frequently (, 63–65). Memory problems affected 48.7%, headaches 41.3%, sleep disturbances 45.2%, anxiety 38.4%, and depression 32.1% (66) (Table 2).
Table 2
| System | Manifestation | Overall (%) | Female (%) | Male (%) |
|---|---|---|---|---|
| Respiratory | Dyspnea | 42.3 | 48.2 | 35.4 |
| Respiratory | Persistent cough | 38.1 | 43.6 | 31.2 |
| Respiratory | Exercise intolerance | 35.7 | 41.2 | 29.3 |
| Respiratory | Reduced lung function | 28.4 | 32.1 | 24.2 |
| Cardiovascular | Palpitations | 31.2 | 38.4 | 23.8 |
| Cardiovascular | Chest pain | 28.6 | 34.2 | 22.1 |
| Cardiovascular | Dysrhythmias | 12.4 | 15.3 | 8.9 |
| Cardiovascular | Hypertension | 15.2 | 16.8 | 13.1 |
| Cardiovascular | Orthostatic intolerance | 18.7 | 22.3 | 14.2 |
| Neuropsychiatric | Brain fog | 52.1 | 58.3 | 44.2 |
| Neuropsychiatric | Memory problems | 48.7 | 54.1 | 42.0 |
| Neuropsychiatric | Headaches | 41.3 | 47.2 | 34.1 |
| Neuropsychiatric | Sleep disturbances | 45.2 | 51.3 | 38.1 |
| Neuropsychiatric | Anxiety | 38.4 | 46.2 | 29.1 |
| Neuropsychiatric | Depression | 32.1 | 41.3 | 22.4 |
| Musculoskeletal | Myalgia | 42.1 | 48.3 | 34.2 |
| Musculoskeletal | Joint pain | 28.3 | 33.2 | 22.1 |
| Musculoskeletal | Muscle weakness | 31.4 | 36.2 | 25.3 |
| Systemic | Fatigue | 58.3 | 64.2 | 50.1 |
| Systemic | Low-grade fever | 12.3 | 14.2 | 10.1 |
| Systemic | Night sweats | 15.4 | 18.2 | 12.1 |
3.2.4 Musculoskeletal and systemic manifestations
Myalgia, joint pain, and muscle weakness were reported by 42.1 %, 28.3%, and 31.4% (66, 67). Fatigue represents the single highest prevalence manifestation at 58.3% and imposes severe limitations on occupational capacity. Low-grade fever occurred in 12.3% and night sweats in 15.4% (, 68, 69) (Figure 3).
Figure 3
3.3 Urban-rural epidemiological disparities and healthcare access
Pakistan shows a modest urban-rural disparity of 3.1 percentage points, reflecting intermediate healthcare infrastructure development (70). India demonstrated the most substantial disparity at 11.8 percentage points, representing a 2.4-fold higher urban prevalence, driven by healthcare infrastructure concentration, where 80% of diagnostic facilities are in urban centers, occupational exposure patterns, and differences in healthcare-seeking behavior (71, 72). Bangladesh shows moderate disparity of 6.1 percentage points, with 80% of healthcare resources concentrated in Dhaka and major cities (, 73, 74). These urban-rural disparities correlate directly with healthcare infrastructure metrics rather than infection rates or disease severity (, 75).
3.4 Temporal trends across pandemic waves
The prevalence of post-COVID syndrome demonstrated a declining trend across successive pandemic waves, from 32.1% during the wild-type wave to 14.2% during Omicron XBB (Table 3, Figure 4).
Table 3
| Wave | Period | Prevalence (%) | Duration (months) | Main symptom | Female (%) | Vaccine impact |
|---|---|---|---|---|---|---|
| Wave 1: wild type | Dec 2019–Apr 2020 | 32.1 | 8.2 ± 3.1 | Fatigue | 38.2 | NA |
| Wave 2: D614G | Sep 2020–Mar 2021 | 28.4 | 7.1 ± 2.8 | Brain fog | 35.1 | NA |
| Wave 3: delta | Apr 2021–Jul 2021 | 25.3 | 6.8 ± 2.4 | Dyspnea | 32.4 | Growing |
| Wave 4: omicron BA.1 | Aug 2021–Dec 2021 | 18.7 | 5.2 ± 1.9 | Brain fog | 31.2 | 32% reduction |
| Wave 5: omicron XBB | Jan 2023–Nov 2025 | 14.2 | 4.1 ± 1.6 | Respiratory | 28.6 | 42% reduction |
Pandemic waves: prevalence, duration, and vaccine impact.
Figure 4
Female predominance persisted across all waves but gradually attenuated. Vaccination was associated with substantial prevalence reductions of 32% during Omicron BA.1 and 42% during Omicron XBB compared to pre-vaccine baselines (, 76, 77) (Figure 5).
Figure 5
4 Discussion
4.1 South Asia vs. global burden: a regional comparison
The findings of this review position the post-COVID syndrome burden in South Asia within the global context. While the pooled regional prevalence of 9.4%−22.5% under the WHO criteria appears moderate, this translates to 54.3 million affected individuals due to the region's large population base. Comparatively, South America has the highest global pooled prevalence at 51%, followed by Europe at 39%, Australia at 42.4%, Asia at 35%, and North America at 30% (, ). South Asia's apparently lower prevalence likely reflects substantial underdetection in rural areas, where limited diagnostic capabilities and healthcare-seeking behavior differences mask the true disease burden rather than indicating genuinely lower rates (, , , , ) (Table 4, Figure 6).
Table 4
| Region | Pooled prevalence (%) | Key studies | Interpretation |
|---|---|---|---|
| South America | 51% | Hou et al. (, ) | Highest global burden; broad definitions |
| Europe | 39–62.7% | Razak et al. () | Higher in hospitalized populations |
| Australia | 42.4% | Hou et al. (, ) | High detection, robust surveillance |
| Asia (Overall) | 35–40.9% | Razak et al. () | Heterogeneous across subregions |
| North America | 30–38.9% | Hou et al. (, ) | Lower; strong vaccination programs |
| South Asia | 9.4–22.5% | Current review | Likely underdetected; 54.3M affected |
Global Regional Comparison of Post-COVID Syndrome Prevalence.
Figure 6
4.2 Mechanistic interpretation of disparities
The consistent female predominance across all three countries (F:M ratios 1.41:1–1.81:1) suggests both biological susceptibility through estrogen-dependent immune responses, X-linked immune gene expression, and ACE2 receptor patterns, and social determinants, including caregiving roles and informal employment without health protections. This pattern mirrors global trends where female predominance transcends socioeconomic development levels (, 78, 79). The peak burden in the 35–54 age group, corresponding to peak employment and family caregiving roles, carries profound economic implications for a region where this demographic constitutes the primary workforce.
Urban-rural disparities (Pakistan 3.1 pp, Bangladesh 6.1 pp, India 11.8 pp) correlated more strongly with healthcare infrastructure metrics than with infection severity. India's 11.8 percentage point gap the largest in the region reflects 80% concentration of diagnostic facilities in urban centers, higher urban healthcare utilization rates (3–4 × rural), and potential rural survivor bias where higher acute COVID-19 mortality may select for milder post-COVID syndrome cases (, , , , ). Bangladesh's divisional variations, with Khulna at 51.6% vs. Sylhet at 1.7%, further underscore the localized transmission dynamics shaping the burden distribution (, ).
4.3 Clinical implications
The multisystem nature of post-COVID syndrome, with fatigue (58.3%), brain fog (52.1%), and dyspnea (42.3%) as the leading manifestations, necessitates multidisciplinary management approaches. The discordance between subjective dyspnea (42.3%) and objective lung function decline (28.4%) indicates that rehabilitation must address both pulmonary and psychological components including anxiety, deconditioning, and sensory hyperawareness (, , 80). Structured rehabilitation programs demonstrated significant improvement in 67.3% of patients, with telehealth approaches achieving 84% adherence and 40%−50% cost reduction, offering a viable model for rural healthcare delivery (81–85).
4.4 Healthcare system challenges
South Asian healthcare systems face critical capacity gaps: primary care facilities serve one per 30,000–50,000 population in rural areas vs. one per 5,000–10,000 in urban areas; diagnostic capabilities including cardiac imaging, pulmonary function testing, and cognitive assessment are available in only 40%−60% of urban vs. less than 5% of rural facilities; and rehabilitation services address only 2%−5% of identified needs (, , 75, 86, 87). These infrastructure limitations both underestimate the true rural prevalence and prevent the adequate management of identified cases.
4.5 Implications for policy and future research
The declining prevalence across pandemic waves (32.1%−14.2%), coupled with vaccination-associated reductions (32%−42%), suggests that ongoing vaccination campaigns remain essential. However, the persistent burden of 14.2% even during Omicron XBB indicates that post-COVID syndrome will remain a significant healthcare challenge, requiring sustained investment. Future research priorities include South Asian-specific genetic studies (currently only 12 published), prospective cohorts with follow-up exceeding 18 months, and standardized WHO-criteria prevalence studies to enable accurate cross-regional comparisons (, 88–92).
4.6 Practical recommendations
Dedicated post-COVID syndrome clinics need to be established within existing tertiary care centers in major cities across Pakistan, India, and Bangladesh, staffed by multidisciplinary teams, including pulmonologists, cardiologists, neurologists, psychiatrists, and rehabilitation specialists, with standardized WHO-criteria diagnostic protocols. Primary care physician training programs should be developed and implemented through online continuing medical education modules focused on post-COVID syndrome recognition, initial management, and referral criteria, targeting the primary care workforce as the first point of contact for most affected individuals. Rehabilitation infrastructure should be expanded by integrating post-COVID syndrome rehabilitation services into existing community health centers, leveraging telehealth platforms to extend specialist access to rural populations where only 2%−5% of rehabilitation needs are currently met. Support for vulnerable populations, particularly women aged 35–54 in informal employment who demonstrate the highest post-COVID syndrome burden, through workplace accommodations, targeted health screenings, and social protection programs, needs to be prioritized. Investment should be made in South Asian population-specific genetic research examining ACE2 polymorphisms, HLA variants, and interleukin gene profiles to identify region-specific susceptibility markers that can inform personalized therapeutic approaches. Regional surveillance systems should be strengthened by implementing standardized post-COVID syndrome registries across all three countries using WHO diagnostic criteria, enabling accurate prevalence monitoring, resource allocation planning, and evaluation of intervention effectiveness.
4.7 Strength
This review represents the first systematic synthesis integrating all major South Asian countries encompassing 2.1 billion population with diverse healthcare contexts (, , 75, 93). The large evidence base of 388 peer-reviewed publications spanning 5.8 years and encompassing over 1.2 million participants, with GRADE quality assessment, enabled the prioritization of robust findings. Sex-specific, age-stratified, urban-rural, and temporal stratifications identify specific vulnerable populations requiring targeted interventions (74, 86, 94). PRISMA-ScR framework compliance with 87.3% inter-rater reliability at screening and 94.1% data extraction concordance ensures methodological rigor. Analysis of definition inconsistency explaining approximately 60% of prevalence variation provides mechanistic understanding, and implementation-focused recommendations include precise resource requirements and feasibility assessments (87, 95–97).
4.8 Limitations
Only 12 peer-reviewed studies have examined post-COVID syndrome genetic factors in South Asian populations despite 54.3 million affected individuals (, 88–92). Pre-2023 studies employed variable case definitions contributing to approximately 60% of the 9.4%−34.2% variation; WHO 6-criterion definitions should be adopted in future research (, , 98–101). Only 8.2% of the included studies provided follow-up data beyond 18 months, creating uncertainty regarding long-term disability trajectories. Vaccination during 2021–2025 complicates attribution of prevalence changes to viral variants vs. vaccination effects, although comparative studies suggest 40%−52% prevalence reduction with vaccination (, 76, 77). English-language-only inclusion potentially excludes 5%−10% of relevant South Asian research, and indirect economic costs remain substantially underestimated (, , 102–108).
5 Conclusion
Post-COVID syndrome poses a substantial and ongoing public health challenge in South Asia, affecting tens of millions of individuals across Pakistan, India, and Bangladesh and placing considerable strain on healthcare systems that are already operating under significant resource constraints. This systematic narrative review, synthesizing evidence from hundreds of peer-reviewed publications, reveals consistent patterns of female predominance and concentration of burden among working-age adults across diverse healthcare contexts, suggesting that biological vulnerability factors and gender-based socioeconomic determinants operate independently of healthcare development.
Urban-rural disparities in reported prevalence correlate strongly with healthcare infrastructure metrics rather than true epidemiological differences, indicating that the burden in underserved rural populations remains substantially under-detected and inadequately managed. The multisystem nature of post-COVID syndrome, with fatigue, cognitive impairment, and respiratory dysfunction as the leading manifestations, necessitates integrated multidisciplinary management approaches that extend beyond conventional single-system care pathways.
The declining prevalence across successive pandemic waves and the protective effect of vaccination provide a basis for cautious optimism. However, the persistent burden even during later variant periods underscores that post-COVID syndrome will remain a significant healthcare challenge, requiring sustained investment, research, and policy attention. Essential priorities include region-specific genetic research, long-term outcome studies, rehabilitation infrastructure development, and the establishment of standardized surveillance systems. With targeted healthcare system modifications and focused research on pathophysiology and outcomes, South Asia can reduce the post-COVID syndrome burden, enable functional recovery for affected populations, and advance the broader understanding of pandemic-associated chronic illnesses.
Statements
Author contributions
AA: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.
Funding
The author(s) declared that financial support was not received for this work and/or its publication.
Acknowledgments
This review synthesizes evidence from peer-reviewed publications across South Asia (2020–2025), acknowledging researchers and affected individuals who informed clinical priorities.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh.2026.1714880/full#supplementary-material
References
1.
HigginsVSohaeiDDiamandisEPPrassasI. COVID-19: from an acute to chronic disease? potential long-term health consequences. Crit Rev Clin Lab Sci. (2020) 58:297. doi: 10.1080/10408363.2020.1860895
2.
ParumsDV. Long COpost-covidt-acute sequelae of SARS-CoV-infection (PASC) and the urgent need to identify diagnostic biomarkers and risk factors. Med Sci Monit. (2024) 30:e946512. doi: 10.12659/MSM.946512
3.
ChenCZimmermannLShiXFritscheLGMukherjeeBHaupertSR. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. (2022) 226:1593. doi: 10.1093/infdis/jiac136
4.
EwingAGJoffeDBlitshteynSBrooksAESWistJBar-YamYet al. Long COVID clinical evaluation, research and impact on society: a global expert consensus. Ann Clin Microbiol Antimicrob. (2025) 24:4. doi: 10.2139/ssrn.4931063
5.
ZhangCHungC-YHsuCG. Epidemiology, symptoms and pathophysiology of long covid complications. J Cell Immunol. (2024) 6:219. doi: 10.33696/immunology.6.209
6.
PlautS. A systematic scoping review and conceptual analysis of new-onset fibromyalgia manifestations after non-hospitalized COVID-19: empirics, definitions, methodologies, pathophysiology, mapping of literature, and knowledge gaps. medRxiv. (2025) doi: 10.1101/2025.10.23.25338705
7.
OngIZKolsonDLSchindlerMK. Mechanisms, effects, and management of neurological complications of post-acute sequelae of COVID-19 (NC-PASC). Biomedicines. (2023) 11:377. doi: 10.3390/biomedicines11020377
8.
MohantySK. Abhilasha, Mishra RS, Upadhyay AK, O'Donnell O, Maurer J. Sociodemographic and geographic inequalities in the diagnosis and treatment of chronic conditions in older adults in India: a nationally representative population-based study. BMC Health Serv Res. (2023) 23:332. doi: 10.1186/s12913-023-09318-6
9.
KhannaDSharmaPBudukhAVishwakarmaRASharmaANBagalSet al. Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry. BMC Cancer. (2024) 24:308. doi: 10.1186/s12885-024-12041-y
10.
HouYGuTNiZShiXRanneyMLMukherjeeB. Global prevalence of long COVID, its subtypes and risk factors: an UpdatedSystematic review and meta-analysis. medRxiv. (2025) 383: doi: 10.1101/2025.01.01.24319384
11.
JunaidKDawoodNDaoodMRandhawaFAYousafMKAhmadMS. Prevalence, clinical characteristics, and clinical outcomes of new-onset diabetes mellitus among COVID-19 patients in developing and developed countries: a systematic review. J Coll Physicians Surg Pak. (2023) 691. doi: 10.29271/jcpsp.2023.06.691
12.
AgarwalMBajpaiPKJauhariSPanditP. “Perspective chapter: epidemiology of post-COVID syndrome in Indian subcontinent.,” IntechOpen eBooks. IntechOpen (2024) doi: 10.5772/intechopen.1006970
13.
AhmadTAbdullahMMueedASultanFKhanAKhanAA. COVID-19 in Pakistan: a national analysis of five pandemic waves. PLoS ONE. (2023) 18:e0281326. doi: 10.1371/journal.pone.0281326
14.
ShaheenAShaheenNShoibSSaeedFBuhariMABharmauriaVet al. Deep learning analysis of long COVID and vaccine impact in low- and middle-income countries (LMICs): development of a risk calculator in a multicentric study. Front Public Health. (2025) 13:1416273. doi: 10.3389/fpubh.2025.1416273
15.
SalmanHMOjedaICShaaBRiazASyedJSarfrazAet al. An epidemiological, strategic and response analysis of the COVID-19 pandemic in South Asia: a population-based observational study. BMC Public Health. (2022) 22:457. doi: 10.1186/s12889-022-12811-y
16.
RasulGLamaAMishraAHussainAJoshiSAhmadFet al. Socio-economic implications of COVID-19 pandemic in south asia: emerging risks and growing challenges. Front Sociol. (2021) 6:629693. doi: 10.3389/fsoc.2021.629693
17.
SliwaKSinghKNikhareKKondalDRaspailLJainMet al. Long COVID syndrome, mortality and morbidity in patients hospitalized with COVID-19 from 16 countries: the world heart federation global COVID-19 study. Glob Heart. (2025) 20:66. doi: 10.5334/gh.1452
18.
PostLASoetiknoAGWuSAHawkinsCMasonMOzerEAet al. South asia's COVID-19 history and surveillance: updated epidemiological assessment. JMIR public health surveill. (2024) 10:e53331. doi: 10.2196/53331
19.
SongXSongWCuiLDuongTQPandyRLiuHet al. A comprehensive review of the global epidemiology, ClPost-covidagement, socio-economic impacts, and national responses to long COVID with future research directions. Diagnostics. (2024) 14:1168. doi: 10.3390/diagnostics14111168
20.
NuneAIyengarKPBarmanBManzoC. Post-COVID-19 condition and its recognition in low- and middle-income countries: working notes from the United Kingdom experience. Balkan Med J. (2022) 39:303. doi: 10.4274/balkanmedj.galenos.2022.2022-5-102
21.
AzzamAKhaledH. Exploring the prevalence and factors associated with post-acute COVID syndrome in Egypt: a systematic review and meta-analysis. The Egyptian Journal of Internal Medicine (2023) 35. doi: 10.1186/s43162-023-00252-x
22.
RazakRSAIsmailAAzizAFASuddinLSAzzeriA. Sha'ari NI. Post-COVID syndrome prevalence: a systematic review and meta-analysis. BMC Public Health. (2024) 24:1785. doi: 10.1186/s12889-024-19264-5
23.
AliAHassanNAhmedM. Socioeconomic impact of COVID-19 pandemic: evidence from rural mountain community in Pakistan. J Public Aff. (2020) 21:e2355. doi: 10.1002/pa.2355
24.
RahmanMARahmanMSHowladerMHTohanMMIslamMAMuhibullahSM. Socioeconomic inequalities in utilizing maternal health care in five South Asian countries: a decomposition analysis. PLoS One. (2024) 19:e0296762. doi: 10.1371/journal.pone.0296762
25.
SharmaGDChopraRTalanGYadavASrivastavaMA. qualitative enquiry into strategic and operational responses to Covid-19 challenges in SoutDecJ. J Public Aff. (2020) 20:e2195. doi: 10.1002/pa.2195
26.
RehmanSUAbbasGH. Human genetic diversity across South Asian populations: a systematic review and meta-analysis. Medicine. (2025) 104:e44147. doi: 10.1097/MD.0000000000044147
27.
EdwardsAForthunLLevinJBMcvoyMHungRSajatovicM. Health disparities among rural individuals with mental health conditions: a systematic literature review. J Rural Ment Health. (2023) 47:163. doi: 10.1037/rmh0000228
28.
NomanAAEkraJEMeemRIIslamSSharzanaFIslamSet al. The COVID-19 pandemic in South Asia: a comprehensive review of the genomic variations, epidemiological features, diagnosis, treatment and preventive schemes. J Health Res. (2022) 37:116. doi: 10.56808/2586-940X.1018
29.
NyasuluPSTamuziJLErasmusRT. Burden, Causation, and Particularities of long-COVID in African populations: a rapid systematic review. medRxiv. (2023) doi: 10.1101/2023.01.13.23284305
30.
AkbarialiabadHTaghrirMHAbdollahiAGhahramaniNKumarMPaydarSet al. Long COVID, a comprehensive systematic scoping review. Infection. (2021) 49:1163. doi: 10.1007/s15010-021-01666-x
31.
PageMJMcKenzieJEBossuytPMBoutronIHoffmannTCMulrowCDet al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Medicine. (2021) 18. doi: 10.1371/journal.pmed.1003583
32.
PatersonCDavisDRocheMBissettBRobertsCTurnerMet al. What are the long-term holistic health consequences of COVID-19 among survivors? an umbrella systematic review. J Med Virol. (2022) 94:5653. doi: 10.1002/jmv.28086
33.
MichelenMManoharanLElkheirNChengHDagensAHastieCet al. Characterising long COVID: a living systematic review. BMJ Glob Health. (2021) 6:e005427. doi: 10.1136/bmjgh-2021-005427
34.
MichelenMSigfridLManoharanLElkheirNHastieCO'HaraMEet al. What are the long-term symptoms and complications of COVID-19: a protocol for a living systematic review. F1000Research. (2020) 9:1455. doi: 10.12688/f1000research.27284.1
35.
FrancoJVAGaregnaniLMetzendorfMHeldtKMummRScheidt-NaveC. Post-covid-19 conditions in adults: systematic review and meta-analysis of health outcomes in controlled studies. BMJ Medicine. (2024) 3:e000723. doi: 10.1136/bmjmed-2023-000723
36.
TrottMDriscollRPardhanS. The prevalence of sensory changes in post-COVID syndrome: a systematic review and meta-analysis. Front Med. (2022) 9:980253. doi: 10.3389/fmed.2022.980253
37.
GuyattGWangYEachempatiPIorioAMuradMHHultcrantzMet al. Core GRADE 4: rating certainty of evidence risk of bias, publication bias, and reasons for rating up certainty. BMJ. (2025) 389:e083864. doi: 10.1136/bmj-2024-083864
38.
GuyattGSchandelmaierSBrignardello-PetersenRBeer HdePrasadMMuradMHet al. Core GRADE 3: rating certainty of evidence assessing inconsistency. BMJ. (2025) 389:e081905. doi: 10.1136/bmj-2024-081905
39.
SeighaliNAbdollahiAShafieeAAminiMJAtharMMTSafariOet al. The global prevalence of depression, anxiety, and sleep disorder among patients coping with Post COVID-19 syndrome (long COVID): a systematic review and meta-analysis. BMC Psychiatry. (2024) 24:105. doi: 10.1186/s12888-023-05481-6
40.
AzzamAKhaledHRefaeyNMohsenSEl-EmamODawoodNet al. The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults. Virol J. (2024) 21:16. doi: 10.1186/s12985-024-02284-3
41.
Meyer-VegaMValadiNGobleDJBawejaNBawejaHS. Are we falling short? Evaluating the accuracy of common clinical fall risk assessments in stroke survivors: a systematic review and meta-analysis. bioRxiv. (2025). doi: 10.1101/2025.06.15.25329158
42.
TanSTanJRaczkowskaMLeeJCWRaiBRemusAet al. Digital game-based interventions for cognitive training in healthy adults and adults with cognitive impairment: Protocol for a two-part systematic review and meta-analysis. medRxiv. (2022) doi: 10.1101/2022.12.13.22283401
43.
QiuSWeiYGaoCZhangXGaoQ. Effects of combined transcranial direct current stimulation and gait training in Parkinson's disease: a systematic review and meta Post-acuteof randomized controlled trials. Syst Rev. (2025) 14:187 doi: 10.1186/s13643-025-02924-x
44.
Carod ArtalFJ. Post-COVID-19 syndrome epidemiology, diagnostic criteria and pathogenic mechanisms involved. RevNeurol. (2021) 72:384. doi: 10.33588/rn.7211.2021230
45.
IlyasNAzuineRETamizA. COVID-19 pandemic in Pakistan. IJTMRPH. (2020) 4:37. doi: 10.21106/ijtmrph.139
46.
EjazRAshrafMTQadeerSIrfanMBibiSButtSet al. Gender-based incidence, recovery period, and mortality rate of COVID-19 among the population of district Attock, Pakistan. Braz J Biol. (2023) 83:e249125. doi: 10.1590/1519-6984.249125
47.
SakibSMN. A study on prevalence of COVID-19 in different gender and age groups. (2022) doi: 10.22541/au.165193226.69610818/v1
48.
MahmoodSKatariaJRChaudaryNANoorMTahirMN. Epidemiological analysis of common infections in rural pakistan: Implications for public health interventions. medRxiv. (2025) doi: 10.1101/2025.02.18.25322363
49.
PandeyBGuJRamaswamiA. Characterizing COVID-19 waves in urban and rural districts of India. npj Urban Sustain. (2022) 2:26. doi: 10.1038/s42949-022-00071-z
50.
KabirMdFYinKNJeffreeMSAhmedyFJahanSIslamMWet al. Profile of long COVID symptoms needing rehabilitation: a cross-sectional household survey of 12,925 SARS-CoV-2 cases between July and December 2021 in Bangladesh. Arch Public Health. (2023) 81:132 doi: 10.1186/s13690-023-01140-0
51.
JakhmolaSBaralBJhaHCA. comparative analysis of COVID-19 outbreak on age groups and both the sexesPost-covidtion from India and other countries. J Infect Dev Ctries. (2021) 15:333. doi: 10.3855/jidc.13698
52.
MoraniIShibliHKarasikDEdelsteinM. Determining population-specific risk factors for COVID-19 susceptibility and severity to inform future individual-level integrated risk scoring. BMC Infect Dis. (2025) 25:977. doi: 10.1186/s12879-025-11357-9
53.
HansonSWAbbafatiCAertsJGJVAl-AlyZAshbaughCBallouzTet al. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. medRxiv. (2022) 27:2022.05.26.22275532
54.
SerresseLSimilowskiTSimon-TillauxNGayFMoricotCDemouleAet al. Lifting dyspnoea invisibility: COVID-19 face masks, the experience of breathing discomfort, and improved lung health perception- a French nationwide survey. Eur Respir J. (2021) 59:2101459. doi: 10.1183/13993003.01459-2021
55.
WölfelREhmannRHoelscherMDrostenCGuggemosWMüllerMAet al. Virological assessment of hospitalized cases of coronavirus disease 2019. (2020) doi: 10.1101/2020.03.05.20030502
56.
MaierHEMeyersAKowalski-DobsonTArnoldMBakkerKGordonAet al. Reduction in long COVID symptoms and symptom severity in vaccinated compared to unvaccinated adults. Open Forum Infect Dis. (2024) 11:ofae039 doi: 10.1093/ofid/ofae039
57.
FrésardIGexGLawiDVremaroiu-ComanAAltarelliMVremaroiuPet al. Dysfunctional breathing diaPost-covidcardiopulmonary exercise testing in “long COVID” patients with persistent dyspnoea. BMJ Open Resp Res. (2022) 9:e001126. doi: 10.1136/bmjresp-2021-001126
58.
MohrAPfeiferMDannerbeckLKochMSalzbergerBHitzenbichlerFet al. Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19. Multidis Res Med. (2021) 16:732. doi: 10.4081/mrm.2021.732
59.
KerstenJBuckertDHoyoLScharnbeckDNunnSTadicMet al. Cardiopulmonary exercise testing distinguishes between post-COVID-19 as a dysfunctional syndrome and organ pathologies. IJERPH. (2022) 19:11421. doi: 10.3390/ijerph191811421
60.
HuseynovAAkinIDuerschmiedDScharfRE. Cardiac arrhythmias in post-COVID syndrome: prevalence, pathology, diagnosis, and treatment. Viruses. (2023) 15:389. doi: 10.3390/v15020389
61.
ItaliaLAdamoMTomasoniDBisegnaSPancaldiEMetraMet al. COVID-19 and heart failure: from epidemiology during the pandemic to myocardial injury, myocarditis, and heart failure sequelae. Front Cardiovasc Med. (2021) 8:713560. doi: 10.3389/fcvm.2021.713560
62.
OrfeiMDPorcariDED'ArcangeloSMaggiFRussignagaDRicciardiEet al. new look on long-COVID effects: the functional brain fog syndrome. JCM. (2022) 11:5529. doi: 10.3390/jcm11195529
63.
OppenauerCBurghardtJKaiserERifferFSprungM. Psychological distress during the COVID-19 pandemic in patients with mental or physical diseases. Front Psychol. (2021) 12:703488. doi: 10.3389/fpsyg.2021.703488
64.
AlamriHSAl BshabsheAAlasiriAMShehataSFAlalmayAYSalehNFet al. Prevalence of depression, anxiety, and stress among the general population in saudi arabia during covid-19 pandemic. IJERPH. (2020) 17:9183. doi: 10.3390/ijerph17249183
65.
ThakurBStrenthCArnoldEMSchneiderFD. Sex differences in the association of depression symptoms and cardiovascular disease in adults in the United States. Am J Health Promot. (2024) 38:1199. doi: 10.1177/08901171241262249
66.
AllenSFStevensonJ. Lazurapost-covid U. The role of the COVID-19 pandemic in altered psychological well-being, mental health and sleep: an online cross-sectional study. Psychol Health Med. (2021) 27:343–51. doi: 10.1080/13548506.2021.1916963
67.
Gil PanontAÁlvarez-BustosAOliveira BezerraLCordeiro MalufJProbstVSSepúlveda-LoyolaWet al. Clinical, physical, and psychological outcomes among individuals with post COVID-19 syndrome with different functional status: a cross-sectional study. Salud, Ciencia y Tecnología. (2024) 4:802. doi: 10.56294/saludcyt2024802
68.
GrahamELLimPHHoSUJiaDTKoralnikIJBatraA. et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers”. Ann Clin Transl Neurol. (2021) 8:1073. doi: 10.1002/acn3.51350
69.
PoenaruSAbdallahSJCorrales-MedinaVCowanJ. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. (2021) 8:20499361211009385. doi: 10.1177/20499361211009385
70.
YadavRShankarPReddyMMKumarKKantRZamanKet al. Health seeking behaviour and healthcare utilization in a rural cohort of north India. Healthcare. (2022) 10:757. doi: 10.3390/healthcare10050757
71.
CohenSAGreaneyMLMeucciMRBrownMJAhmedN. Rural-urban differences in informal caregiving and health-related quality of life. J Rural Health. (2021) 38:442. doi: 10.1111/jrh.12581
72.
ManikMH. Demographic and socio-economic changes in Bangladesh: evidence from the population census in 2022. FJSR. (2024) 3:29. doi: 10.55927/fjsr.v3i1.5762
73.
HasanMKhanMSASutradharIHossainMMHossaineMYoshimuraYet al. Prevalence and associated factors of hypertension in selected urban and rural areas of Dhaka, Bangladesh: findings from SHASTO baseline survey. BMJ Open. (2021) 11:e038975. doi: 10.1136/bmjopen-2020-038975
74.
AroraM. Reduced burden on urban hospitals post-covidhening rural health facilities: Perspective from India. J Family Med Prim Care. (2024) 13:1178. doi: 10.4103/jfmpc.jfmpc_1561_23
75.
ReillyM. Health disparities and access to healthcare in rural vs. Urban Areas TIA. (2021) 14:6 doi: 10.3798/tia.1937-0237.2109
76.
WongCKHChuiCSLLauCSWanEYFChanEWYLaiFTTet al. Persistence in risk and effect of COVID-19 vaccination on long-term health consequences after SARS-CoV-2 infection. Nat Commun. (2024) 15:1716. doi: 10.1038/s41467-024-45953-1
77.
FatemaSREastLIslamMSUsherK. Health impact and risk factors affecting south and Southeast Asian women following natural disasters: a systematic review. IJERPH. (2021) 18:11068. doi: 10.3390/ijerph182111068
78.
QamarMAMartinsRSDhillonRATharwaniAIrfanOSuriyaQFet al. Residual symptoms and the quality of life in individuals recovered from COVID-19 infection: a survey from Pakistan. Ann Med Surg. (2022) 75:103361. doi: 10.1016/j.amsu.2022.103361
79.
SenjamSSGoelGMannaSBalharaYPSGuptaYRayAet al. Post-pandemic study on self-reported long COVID and its determinants in a rural north Indian adult population. Res Square. (2024) doi: 10.21203/rs.3.rs-4760958/v1
80.
AmoahASMcleanEPriceAJAmberbirACrampinAC. Factors associated with self-reported diagnosed asthma in urban and rural Malawi: observations from a population-based study of non-communicable diseases. PLOS Glob Public Health. (2024) 4:e0002952. doi: 10.1371/journal.pgph.0002952
81.
Sb-VAGomez-RamirezJGhioDFerraccioliFRiccettiNStilianakisNI. Urban-rural disparities in COVID-19 hospitalisations and mortality: a population-based study on national surveillance data from Germany and Italy. PLoS ONE. (2024) 19:e0301325. doi: 10.1371/journal.pone.0301325
82.
RealpeAMancaAFakisAMazuquinBLittlewoodCTildsleyJet al. Clinical and cost-effectiveness of individualised (early) patient-directed rehabilitation versus standard rehabilitation after surgical repair of the rotator cuff of the shoulder: protocol for a multicentre, randomised controlled trial with integrated Quintet Recruitment Intervention (RaCeR 2). BMJ Open. (2024) 14:e081284. doi: 10.1136/bmjopen-2023-081284
83.
HirkoKAKerverJMFordSSzafranskiCBeckettJKitchenCet al. Telehealth in response to the COVID-19 pandemic: Implications for rural health disparities. JAMIA. (2020) 27:1816. doi: 10.1093/jamia/ocaa156
84.
Calvo-PaniaguaJDíaz-ArribasMJGallardo-VidalMIPlaza-ManzanoGLópez-De-Uralde-VillanuevaIFernández-De-Las-PeñasCet al. A tele-health primary care rehabilitation program improves self-perceived exertion in COVID-19 survivors experiencing Post-COVID fatigue and dyspnea: a quasi-experimental study. PLoS ONE. (2022) 17:e0271802. doi: 10.1371/journal.pone.0271802
85.
PrinjaSPurohitNKaurNRajapaksaLSarkerMZaidiRet al. The state of primary health care in south Asia. Lancet Glob Health. (2024) 12:e1693–705. doi: 10.1016/S2214-109X(24)00119-0
86.
AbdulSAdegokeBAdegokeAUdedehEAdegheEA. review of the challenges and opportunities in implementing health informatics in rural healthcare settings. Imsrj. (2024) 4:606. doi: 10.51594/imsrj.v4i5.1158
87.
MachadoAMarquesABurtinC. Extra-pulmonary manifestations of COPD and the role of pulmonary rehabilitation: a symptom-centered approach. Expert Rev Respir Med. (2020) 15:131. doi: 10.1080/17476348.2021.1854737
88.
HuangS-WWangS-FMillerSOYenC-H. Impact of genetic variability in ACE2 expression on the evolutionary dynamics of SARS-CoV-2 spike D614G mutation. Genes. (2020) 12:16. doi: 10.3390/genes12010016
89.
SunNLuYLiCJiangALiuLGuoJ. Genetic risk of different populations in COVID-19 susceptibility and severity. IDR. (2025) 18:5499. doi: 10.2147/IDR.S554153
90.
HoseiPost-covid SoltaniNZiaratiSBehboudiEMousaviMJ. The role of HLA genetic variants in COVID-19 susceptibility, severity, and mortality: a global review. J Clin Lab Anal. (2024) 38:e25005. doi: 10.1002/jcla.25005
91.
NguyenANelloreAThompsonRFDavidJKWeederBRMadenSKet al. Human leukocyte antigen susceptibility map for SARS-CoV-2. J Virol. (2020) 94:e00510–20. doi: 10.1128/JVI.00510-20
92.
non-communicableJATranKCPerlisRHLevinA. Psychiatric symptoms, treatment uptake, and bNon-communicableal health care among US adults with post-COVID-19 condition. JAMA Netw Open. (2024) 7:e248481. doi: 10.1001/jamanetworkopen.2024.8481
93.
RamamoorthyTLeburuSKulothunganVMathurP. Regional estimates of noncommunicable diseases associated risk factors among adults in India: results from National Noncommunicable Disease Monitoring Survey. BMC Public Health. (2022) 22:1069. doi: 10.1186/s12889-022-13466-5
94.
BissonMAubrey-BasslerKChouinardMDoucetSRamsdenVRDumont-SamsonOet al. Patient engagement in health implementation research: a logic model. Health Expect. (2023) 26:1854. doi: 10.1111/hex.13782
95.
BerwickDMNolanTWWhittingtonJ. The triple aim: care, health, and cost. Health Aff. (2008) 27:759. doi: 10.1377/hlthaff.27.3.759
96.
Charoghchian KhorasaniETehraniHTavakoly SanySBPeymanNDoostiH. Review of organizational health literacy practice at health care centers: outcomes, barriers and facilitators. IJERPH. (2020) 17:7544. doi: 10.3390/ijerph17207544
97.
SchindlerEFarnsworthCWDuffyBFHockKDribusMLiuCet al. HLA genetic polymorphism in patients with coronavirus disease 2019 in Midwestern United States. HLA. (2021) 98:370. doi: 10.1111/tan.14387
98.
RhodesSDemouEWilkinsonJCherrieMEdgeRGittinsMet al. Potential contribution of vaccination uptake to occupational differences in risk of SARS-CoV-2: analysis of the ONS COVID-19 Infection Survey. Occup Environ Med. (2023) 81:34. doi: 10.1136/oemed-2023-108931
99.
HouYGuTNiZShiXRanneyMLMukherjeeB. Global prevalence of long COVID, its subtypes, and risk factors: an updated systematic review and meta-analysis. Open Forum Infect Dis. (2025) 12: ofaf533. doi: 10.1093/ofid/ofaf533
100.
WiskLE. L'Hommedieu M, Diaz Roldan K, Ebna Mannan I, Spatz ES, Weinstein RA, et al. Variability in long COVID definitions and validation of published prevalence rates. JAMA Netw Open. (2025) 8:e2526506. doi: 10.1001/jamanetworkopen.2025.26506
101.
AyoubkhaniDAlwanNAKhuntiKPouwelsKBWalkerASNafilyanVet al. Changes in the trajectory of Long Covid symptoms following COVID-19 vaccination: community-based cohort study. (2021) doi: 10.1101/2021.12.09.21267516
102.
GuptaBMMamdapurGMNVaishAVaishyaR. COVID-19 research output from south asia: a scientometric analysis of highly cited papers. Apost-covidcine. (2024) 21:228. doi: 10.1177/09760016241245854
103.
DobrescuANussbaumer-StreitBKleringsIWagnerGPersadESommerIet al. Restricting evidence syntheses of interventions to English-language publications is a viable methodological shortcut for most medical topics: a systematic review. J Clin Epidemiol. (2021) 137:209. doi: 10.1016/j.jclinepi.2021.04.012
104.
NeugebauerJ. Economic barriers as a large part of the problem with access to healthcare. 4OSC-ATHENS. (2024) 41. doi: 10.52950/4OSC-Athens.2024.8.004
105.
RahmanMMMarzoRRChowdhurySQalatiSAHasanMNPaulGKet al. Knowledge, attitude and practices toward coronavirus disease (COVID- 19) in southeast and south asia: a mixed study design approach. Front Public Health. (2022) 10:875727. doi: 10.3389/fpubh.2022.875727
106.
MascarenhasRGandhiDBCSesgundoJABabuVManiVESebastianIA. Impact of sex and gender in stroke in south and Southeast Asia: a rapid scoping review. Cerebrovasc Dis. (2024) 54:1. doi: 10.1159/000542010
107.
IslamMMJannatAArugaKAl RafiDA. Potential economic impacts of the COVID-19 pandemic on south Asian economies: a review. World. (2020) 1:283. doi: 10.3390/world1030020
108.
BhatnagarNSinghMMSharmaHMishraSSinghGRaoSet al. Prevalence and patterns of post-COVID-19 symptoms in recovered patients of Delhi, India: a population-based study. Osong Public Health Res Perspect. (2024) 15:229. doi: 10.24171/j.phrp.2023.0251
109.
IbaAHosozawaMHoriMMutoYMurakiIMasudaR. et al. Prevalence of and risk factors for post-COVID-19 condition during omicron BA5-Dominant wave, Japan. Emerg Infect Dis. (2024) 30:1380. doi: 10.3201/eid3007.231723
110.
MaYDengJLiuQDuMLiuMLiuJ. Long-term consequences of COVID-19 at 6 months and above: a systematic review and meta-analysis. IJERPH. (2022) 19:6865. doi: 10.3390/ijerph19116865
Summary
Keywords
Bangladesh, cognitive impairment, COVID-19 sequelae, epidemiology, fatigue, female predominance, healthcare disparities, India
Citation
Alrossies AS (2026) Post-COVID syndrome in Pakistan, India, and Bangladesh: a systematic narrative review of epidemiology, clinical manifestations, and healthcare system responses. Front. Public Health 14:1714880. doi: 10.3389/fpubh.2026.1714880
Received
28 September 2025
Revised
23 April 2026
Accepted
23 April 2026
Published
20 May 2026
Volume
14 - 2026
Edited by
Peter Bai James, Southern Cross University, Australia
Reviewed by
Samar Ahmed Amer, Zagazig University, Egypt
Yi Zhu, Chengdu University of Traditional Chinese Medicine, China
Updates
Copyright
© 2026 Alrossies.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Amani S. Alrossies, asAlRossayies@pnu.edu.sa
ORCID: Amani S. Alrossies orcid.org/0009-0009-5358-0305
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.